OpGen Investor Relations Material
Latest events
Q2 2023
OpGen
Q4 2023
15 Nov, 2024
Q2 2024
19 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from OpGen Inc
Access all reports
OpGen, Inc. is a precision medicine company that focuses on developing molecular diagnostic tools for the detection of infectious diseases. The company's products and services include rapid diagnostic tests and bioinformatics solutions designed to identify bacterial pathogens and antibiotic resistance. OpGen serves healthcare providers and laboratories, aiming to improve patient outcomes through faster, more accurate diagnostics for conditions such as urinary tract infections and bloodstream infections. The company is headquartered in Rockville, United States, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
OPGN
Country
🇺🇸 United States